You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nilotinib

Showing 51 - 75 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Trial in Germany, United Kingdom (Tasigna)

Completed
  • Chronic Myeloid Leukemia
  • Frankfurt/M, Germany
  • +4 more
Dec 6, 2020

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib + LDE225)

Completed
  • Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
  • Nilotinib + LDE225
  • Toronto, Ontario, Canada
  • +6 more
Dec 6, 2020

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Dec 2, 2022

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Nilotinib
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Nilotinib
  • Bordeaux, Aquitaine, France
  • +11 more
Dec 6, 2020

Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib followed by treatment-free
  • Fort Myers, Florida
  • +113 more
Apr 25, 2022

Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Hospital / University Health Network
Oct 29, 2020

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Nilotinib
  • +10 more
  • Bordeaux, France
  • +17 more
Oct 4, 2022

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

Completed
Has Results
  • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
  • nilotinib
  • Loma Linda, California
  • +35 more
Mar 25, 2021

Chronic Myelogenous Leukemia Trial in Turkey (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib
  • Eskisehir, Meselik, Turkey
  • +12 more
Aug 18, 2020

Untreated Adult Acute Myeloid Leukemia Trial in Scottsdale, Rochester (Cytarabine, Daunorubicin Hydrochloride, Laboratory

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +1 more
Aug 4, 2020

The Life After Stopping Tyrosine Kinase Inhibitors Study

Completed
  • Leukemia, Myeloid, Chronic
  • Imatinib (Stopping their TKI)
  • +3 more
  • San Francisco, California
  • +15 more
Jan 3, 2023

Huntington Disease Trial in Washington (Nilotinib 150 MG)

Unknown status
  • Huntington Disease
  • Nilotinib 150 MG
  • Washington, District of Columbia
    Georgetown University Medical Center
Feb 19, 2020

Parkinson Disease Trial in United States (Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), Cohort 2: Nilotinib Oral Capsules

Completed
Has Results
  • Parkinson Disease
  • Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)
  • +2 more
  • Birmingham, Alabama
  • +23 more
Jul 21, 2020

(PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral Trial in Canada, United States (Nilotinib)

Completed
  • Bone Marrow Transplant Failure
  • +2 more
  • Nilotinib
  • Stanford, California
  • +4 more
Apr 13, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Minimal Residual Disease
  • Goodyear, Arizona
  • +237 more
Jan 3, 2023

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Leukemia Trial in Houston (MEK-162, Nilotinib, Questionnaires)

Terminated
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 10, 2020

BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

Active, not recruiting
  • Chronic Phase Philadelphia Positive
  • +2 more
    • Alessandria, Italy
    • +55 more
    Jan 4, 2022

    Glioma Trial in La Jolla (nilotinib)

    Completed
    Has Results
    • Glioma
    • nilotinib
    • La Jolla, California
      The Rebecca and John Moores UCSD Cancer Center
    Apr 27, 2020

    Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia
    • Birmingham, Alabama
    • +25 more
    Mar 4, 2022

    Philadelphia Positive (Ph+) Chronic Myeloid Leukemia Trial in Moscow (Nilotinib)

    Terminated
    Has Results
    • Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
    • Nilotinib
    • Moscow, Russian Federation
      Novartis Investigative Site
    Dec 9, 2019